Raw Honey for Skin: What the Research Actually Supports
Honey shows up in an enormous range of skincare products, from luxury masks to drugstore cleansers to DIY recipes circulating on social media, and the claims attached to it range from reasonable to wildly overstated. The actual dermatological research is genuinely more interesting than either the marketing or the skepticism, because it includes real clinical trials with real, measurable results, alongside significant limitations that most content citing those trials leaves out entirely.
We've written separately about honey's antibacterial mechanisms and where that evidence is strongest, primarily wound care. This post covers something different: what the research specifically supports for skin as a cosmetic and dermatological application, what the clinical trials actually measured, and where the honest boundaries of that evidence sit.
The humectant mechanism, which is the least controversial thing about honey and skin
The most straightforward, least disputed property honey brings to skin is that it's an effective humectant, meaning it attracts and binds water.
This isn't a marketing claim requiring careful evaluation. It's a straightforward consequence of honey's composition. Honey is roughly 80 percent sugars, primarily fructose and glucose, and sugars are hygroscopic, meaning they naturally draw and hold water molecules. In dermatological terms, humectants are one of three recognized categories of moisturizing ingredients, alongside occlusives, which form a physical barrier reducing water evaporation, and emollients, which fill microscopic gaps between skin cells to improve texture and smoothness. Glycerin, urea, and hyaluronic acid are the humectants most commonly used in commercial skincare, and honey functions through the same basic mechanism.
There's a genuine caveat worth understanding about all humectants, not specific to honey, that gets left out of most product marketing. Humectants draw water from wherever it's available. In high ambient humidity, above roughly 70 percent, they can draw moisture from the air. In dry conditions, they more commonly draw water from the deeper layers of your own epidermis, which can, without a concurrent occlusive ingredient sealing that moisture in, actually increase transepidermal water loss and worsen dryness rather than improving it. This is well documented in clinical dermatology references and it's a real, mechanistic reason why humectants generally work better as part of a formulation that also includes an occlusive or emollient component than they do applied entirely on their own in a dry environment.
The atopic dermatitis research: real, promising, and genuinely limited
This is where honey's skin research gets specific enough to be worth examining closely, and where the difference between what a study found and how it gets cited becomes important.
A 2017 study by Abdullah Alangari and colleagues at King Saud University, published in Immunity, Inflammation and Disease, investigated Manuka honey for atopic dermatitis using an elegant study design: participants with bilateral lesions, meaning matching lesions on both sides of the body, applied Manuka honey to one site overnight for seven consecutive days while leaving the contralateral lesion untreated as a within-person control. Severity was assessed using the Three Item Severity score, a validated clinical measure.
The results were meaningful. Honey-treated lesions showed a statistically significant improvement, with a mean difference of negative 2 points and a p-value below 0.001, while untreated control lesions showed no statistically significant change, with a mean difference of negative 0.7 points and a p-value of 0.15. The treatment was well tolerated, with none of the participants who completed the study reporting adverse events.
The study also included laboratory work investigating why this might happen, which is worth understanding because it moves beyond simple observation. Manuka honey significantly downregulated IL-4-induced CCL26 release from HaCaT cells, a human keratinocyte line, in a dose-dependent manner. CCL26, also called eotaxin-3, is a chemokine involved in recruiting inflammatory cells in allergic skin conditions. The researchers also found that mast cell degranulation was significantly inhibited following honey treatment. Separately, this connects to a well-documented feature of atopic dermatitis: Staphylococcus aureus colonizes the skin of the large majority of people with the condition, and a systematic review pooling data across 95 observational studies found that people with atopic dermatitis had dramatically higher odds of S. aureus colonization compared to healthy controls, with a pooled odds ratio of 19.74. Honey's documented anti-staphylococcal activity offers a plausible second mechanism alongside the anti-inflammatory pathway.
Now the limitations, which matter enormously and which the researchers themselves stated clearly. This was an open-label pilot study, not a randomized controlled trial. It enrolled 16 participants, of whom two withdrew due to worsening symptoms, leaving 14 completers. There was no placebo or vehicle control, meaning the comparison was honey versus nothing rather than honey versus an inactive substance that would control for the effects of simply applying something occlusive and moist to a lesion overnight. The authors' own stated conclusion was that honey is "potentially effective" and that this "needs to be confirmed by randomized and controlled clinical trials," a genuinely appropriate level of caution that gets stripped away in most secondary coverage of this study.
It's also worth noting explicitly that two of sixteen participants withdrew because their symptoms worsened. That's a small number in a small study, and it may or may not have been related to the honey itself, but it's a real detail from the actual data that deserves inclusion rather than omission when discussing tolerability.
What this means practically, and where the boundary sits
The atopic dermatitis findings are genuinely encouraging and mechanistically coherent, which is a meaningful combination. It's not just an observed effect with no plausible explanation, nor is it a plausible mechanism with no clinical observation. Both exist, which is more than can be said for many ingredients marketed for skin.
What it isn't, is established treatment. Atopic dermatitis is a genuine medical condition, and a 14-person open-label pilot study, however well-designed within its constraints, doesn't establish honey as a treatment for it. Anyone managing atopic dermatitis should be working with a dermatologist rather than substituting a supplement or cosmetic product for medical care, and this post isn't suggesting otherwise. The research is worth knowing about precisely because it's real and specific, not because it changes what appropriate care for a diagnosed skin condition looks like.
This is also a good place to be precise about a distinction that matters for the entire category. Most of the encouraging clinical research on honey and skin uses medical-grade honey, which is gamma-irradiated to sterilize it while preserving its active compounds, and typically Manuka specifically, which contains methylglyoxal at concentrations far above other honey varieties and derives much of its documented antibacterial activity from that compound rather than from the hydrogen peroxide pathway most other raw honeys rely on. Retail raw honey, however high quality, is not medical-grade honey and is not typically Manuka. The mechanisms overlap meaningfully but they're not identical, and extrapolating clinical results from a specific medical-grade Manuka preparation directly to any raw honey in a cosmetic formulation is a stretch worth naming rather than glossing over.
The antioxidant and phenolic content angle
Raw honey contains phenolic compounds and flavonoids, and their concentrations vary considerably based on floral source, which is why different honey varieties test differently for antioxidant activity in laboratory settings. Buckwheat honey, for instance, consistently tests higher in phenolic content than lighter varieties like clover.
The reasonable version of what this supports: these compounds have documented antioxidant activity in laboratory testing, and antioxidant activity in skin is a legitimate area of dermatological interest, since oxidative stress from UV exposure and environmental factors contributes to skin aging processes. The less reasonable version, which appears frequently in marketing, is the leap from "contains antioxidant compounds" directly to "reverses skin aging" or similar claims. That leap requires clinical evidence in humans measuring actual skin outcomes, which for honey specifically as a topical antioxidant is considerably thinner than the laboratory data on the compounds themselves.
A useful way to hold this: the antioxidant content is real and measurable, the mechanism by which antioxidants could benefit skin is scientifically legitimate, and the specific clinical evidence that topically applied honey produces measurable anti-aging outcomes in humans is not well established. All three of those statements are true simultaneously.
Acne: where the evidence is weakest
Honey appears frequently in DIY acne remedies and in some commercial acne products, and this is the application where the evidence is thinnest relative to how confidently it's promoted.
The theoretical rationale isn't unreasonable. Acne involves bacterial colonization by Cutibacterium acnes alongside inflammation, and honey has documented antibacterial and anti-inflammatory properties. But rationale isn't evidence, and rigorous clinical trials specifically testing honey for acne with meaningful sample sizes and appropriate controls are largely absent from the literature. What exists tends to be small, poorly controlled, or focused on honey as one component of a multi-ingredient preparation, which makes attributing any observed effect to honey specifically difficult.
There's also a practical consideration specific to acne-prone skin worth raising honestly: honey is sugar-dense, and while it doesn't feed C. acnes in the way sometimes claimed, applying a sticky, sugar-rich substance to acne-prone facial skin and leaving it in prolonged contact isn't obviously beneficial, and individual responses vary. Anyone with acne-prone skin trying honey topically would be sensible to patch test rather than assume it's universally well tolerated, the same general caution we've applied to other ingredients in this series.
What this supports for cosmetic formulations specifically
Bringing this back to the practical question of honey as an ingredient in a rinse-off or leave-on cosmetic product, rather than as a standalone therapeutic application.
In a formulation, honey's most defensible contribution is its humectant function, drawing and binding moisture, which is well established and doesn't require any of the more ambitious clinical claims to be true. Its antibacterial properties contribute meaningfully to a formulation's overall character, and in some cases to preservation, though contact time in a rinse-off product is far too brief for the wound-care-level antibacterial activity documented in clinical research to be the relevant mechanism. The phenolic and antioxidant content is a genuine part of what raw honey brings compared to heavily processed honey, with the caveat about clinical outcomes noted above.
What honey in a cosmetic formulation is not doing is delivering the therapeutic effects documented in the medical-grade Manuka atopic dermatitis research. Different preparation, different honey variety, different concentration, different contact time, different application context. The research is interesting and real, and it applies to a specific set of conditions that a soap or conditioner formulation doesn't replicate.
The honest summary
Raw honey's best-supported property for skin is its function as a humectant, which is mechanistically straightforward and not seriously disputed, with the general caveat that humectants work best alongside occlusive or emollient ingredients rather than in isolation, particularly in dry conditions.
The most compelling clinical research on honey and a specific skin condition comes from a 2017 pilot study on Manuka honey for atopic dermatitis, which found statistically significant improvement in treated lesions alongside plausible anti-inflammatory and anti-staphylococcal mechanisms, and which was explicitly limited by its small size, open-label design, and lack of a vehicle control, limitations the study's own authors clearly stated.
The antioxidant content is real, the mechanism is legitimate, and the human clinical outcome data specifically for topically applied honey is thin. The acne evidence is the weakest of the applications commonly promoted. And medical-grade Manuka honey used in clinical research is meaningfully different from retail raw honey in a cosmetic product, a distinction worth maintaining rather than blurring.
That's a more qualified picture than most honey skincare content offers, and it's the one the actual research supports.
